These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18639651)

  • 1. Estimating the relative hazard by the ratio of logarithms of event-free proportions.
    Perneger TV
    Contemp Clin Trials; 2008 Sep; 29(5):762-6. PubMed ID: 18639651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the risk difference, risk ratio and odds ratio scales for quantifying the unadjusted intervention effect in cluster randomized trials.
    Ukoumunne OC; Forbes AB; Carlin JB; Gulliford MC
    Stat Med; 2008 Nov; 27(25):5143-55. PubMed ID: 18613226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.
    Localio AR; Margolis DJ; Berlin JA
    J Clin Epidemiol; 2007 Sep; 60(9):874-82. PubMed ID: 17689803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of risks associated with multiple events].
    Com-Nougué C; Guérin S; Rey A
    Rev Epidemiol Sante Publique; 1999 Mar; 47(1):75-85. PubMed ID: 10214679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
    Rücker G; Schwarzer G; Carpenter J; Olkin I
    Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating risk difference from relative association measures in meta-analysis can infrequently pose interpretational challenges.
    Murad MH; Montori VM; Walter SD; Guyatt GH
    J Clin Epidemiol; 2009 Aug; 62(8):865-7. PubMed ID: 19230610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tutorial on discrete hazard functions.
    Alemi F
    Qual Manag Health Care; 2007; 16(4):311-20. PubMed ID: 18049384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New statistical methods for the evaluation of cardiovascular risk markers: what the clinician should know.
    Røsjø H; Omland T
    Clin Sci (Lond); 2009 Jun; 117(1):13-5. PubMed ID: 19351327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making sense of odds and odds ratios.
    Grimes DA; Schulz KF
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):423-6. PubMed ID: 18238982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two commonly used methods for exposure-adverse events analysis: comparisons and evaluations.
    Duan JZ
    J Clin Pharmacol; 2009 May; 49(5):540-52. PubMed ID: 19318526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
    Pogue J; Walter SD; Yusuf S
    Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The generalized F distribution: an umbrella for parametric survival analysis.
    Cox C
    Stat Med; 2008 Sep; 27(21):4301-12. PubMed ID: 18407568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative merits of risk ratios and odds ratios.
    Cummings P
    Arch Pediatr Adolesc Med; 2009 May; 163(5):438-45. PubMed ID: 19414690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of peripheral vascular disease on long-term survival after coronary artery bypass graft surgery.
    Chu D; Bakaeen FG; Wang XL; Dao TK; LeMaire SA; Coselli JS; Huh J
    Ann Thorac Surg; 2008 Oct; 86(4):1175-80. PubMed ID: 18805156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk and odds--how to calculate with events].
    Malmquist J
    Lakartidningen; 2002 Feb; 99(8):751-3, 756. PubMed ID: 11894612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparity in outcomes of surgical revascularization for limb salvage. Race and gender are synergistic determinants of vein graft failure and limb loss. Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS. Circulation. 2009; 119: 123-130.
    Kreatsoulas C; Anand SS
    Vasc Med; 2009 Nov; 14(4):397-9. PubMed ID: 19808727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of binary outcomes from two-by-two tables when the length of follow-up varies and hazards are proportional.
    Combescure C; Courvoisier DS; Haller G; Perneger TV
    Stat Methods Med Res; 2011 Oct; 20(5):531-40. PubMed ID: 20716589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Roaming through methodology. XI. 'Odds' and so forth].
    Scholten RJ
    Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2452-4. PubMed ID: 10028324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.